Life Sciences

The company, which provides AI-enabled services to simply provider workflows, will use the funds to accelerate product development and increase market presence.   

The aim of the collaboration is to deliver better cost leadership, productivity enhancement and elicit greater value from the existing relationship.

The astronautics company seeks proposals to study human adaptation in space to enhance health during long missions.

The company will use the funds to grow its handheld histotripsy therapy and expand its team.  

At a Senate confirmation hearing, Kennedy said using AI and telemedicine in rural hospitals will be a priority if he is confirmed as the head of Health and Human Services.   

The funds will be used to increase product offerings, expand the commercial team and move into the substance use disorder space.  

Neurotechnology company, Grey Matter Neurosciences, announced it secured $14 million in seed financing, which will be used to develop an ultrasound headset for individuals with Alzheimer's disease and test that device in clinical trials.

The company, in partnership with Microsoft, aims to develop cancer medicines, followed by treatments for autoimmune diseases and rare conditions.

DeepScribe will be the first ambient AI partner for Flatiron Health, and will integrate with Flatiron's OncoEMR.   

The partnership gives Lantern clients entry into customized substance use disorder treatment and telemedicine services.